Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v1-EN
Language French English
Date Updated 2020-03-05 2020-03-05
Drug Identification Number 00247979 00247979
Brand name ETIBI ETIBI
Common or Proper name ETIBI ETIBI
Company Name BAUSCH HEALTH, CANADA INC. BAUSCH HEALTH, CANADA INC.
Ingredients ETHAMBUTOL HYDROCHLORIDE ETHAMBUTOL HYDROCHLORIDE
Strength(s) 400MG 400MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size n/a n/a
ATC code J04AK J04AK
ATC description DRUGS FOR TREATMENT OF TUBERCULOSIS DRUGS FOR TREATMENT OF TUBERCULOSIS
Reason for shortage Shortage of an active ingredient. Shortage of an active ingredient.
Anticipated start date 2020-03-31 2020-03-31
Actual start date
Estimated end date 2020-05-31
Actual end date 2020-03-02
Shortage status Avoided shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments